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ABSTRACT
Introduction Fetal endoscopic tracheal occlusion in congenital diaphragmatic hernia (CDH) may reduce pulmonary
hypertension and ameliorate postnatal cardiac output. The effects of sustained early (ETO) and late (LTO) tracheal
occlusion on left ventricular (LV) cells in the lamb model have not been described.
Materials and methods CDH was created in lambs at 70 days’ gestation (term= 145 days). ETO (85 days) or LTO
(105 days) was sustained till term. After cesarean section (140 days) fetuses were euthanized and hearts harvested. LV
myocardial cells were studied by histological and immunofluorescence (TGF-beta 1, endothelin-1) assays in CDH,
ETO, LTO, and the control group (two subjects per group). Small intramyocardial arteries were evaluated by
traditional histology.
Results LV myocardial histology in CDH and LTO was similar. ETO-induced LV myocardial cell enlargement and
increased endothelin-1 and TGF-beta 1 staining; a weaker immunofluorescence signal was observed in LTO
compared with ETO. Myocardial vascular wall thickness was greater in CDH than in controls. ETO was associated with
a vascular wall thickness within the range of controls.
Conclusion With only two fetuses in each group, only an explorative evaluation was possible. The time point at which
TO is performed seems to have an effect on cardiac morphology. Functional studies as well as confirmation in clinical
samples are mandatory. © 2016 John Wiley & Sons, Ltd.
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INTRODUCTION
The incidence of congenital diaphragmatic hernia (CDH) is
about 1/3000 live births. Despite improvements in neonatal
care, lung hypoplasia and pulmonary hypertension are the
causes of the high mortality (approximately 40–50%).
Left-sided cardiac structures are underdeveloped in left
diaphragmatic hernia.1–3 The relationship between left heart
dimensions and outcome has not been well characterized.
When prenatally detected, a small left ventricle (LV) is
considered by some as a poor prognostic factor,4–6 since at
delivery it would be less compliant and unable to maintain
normal cardiac function.7,8 However, it has not been defined
whether prenatal indices of left heart size and function are
associated with postnatal outcome in patients with CDH, or
what degree of apparent left heart hypoplasia is compatible
with postnatal survival and a biventricular circulation.3 It
remains unclear whether this is a primary event or anomaly
secondary to direct compression exerted on the heart by the
herniated intra-thoracic organs.8–10 The structural immaturity
of the heart in CDH has already been described in animal
models, and the extracellular matrix alteration seems to
contribute to cardiac maldevelopment.11
Fetal endoscopic tracheal occlusion (FETO) has been
proposed as prenatal therapy to ameliorate the prognosis in
CDH.12–19 FETO, usually performed at 26 to 32weeks of
gestational age, has been shown to increase fetal lung growth.20
Recently, FETO has been applied earlier, at 22–24weeks, in
extreme cases of severe lung hypoplasia with the purpose of
improving the pulmonary response, both at the level of the
airways and vessels.21
Prenatal Diagnosis 2016, 36, 362–367 © 2016 John Wiley & Sons, Ltd.
DOI: 10.1002/pd.4789
While benefits on pulmonary tissue have been reported and
reversal of pulmonary hypoplasia has been documented, the
mortality rate remains high.18,19 The displacement in the
cardiac axis and a smaller LV yet without demonstrable effects
on LV function and conduction has been documented in CDH
human fetuses. So far no adverse changes in the cardiac axis,
LV size, or cardiac function were documented after fetal
intervention.22 So far, no structural changes in CDH
myocardial tissue and its vessels before and after FETO have
been reported in humans or in animal models.
In this pilot study the effects of sustained early (ETO) and
late (LTO) tracheal occlusion on fetal myocardial tissue were
analyzed in the CDH lamb model. These preliminary results
are reported with the aim of adding data on the role of the left
heart impairment in CDH.
MATERIALS AND METHODS
Animals and surgical technique
The experimental protocol was approved by the Local and
National Animal Care and Ethics Committees and was
conducted in accordance with Italian and European
legislation (D.lgs. 116/92, European Directives 86/609/EE
for the protection of animals used in scientific and
experimental studies and 2010-63UE).
Twenty pregnant ewes (Ripollese breed), aged 18–24months,
were enrolled. All animals included in the study were
considered healthy on physical examination. Animals were
allowed to acclimatize for 7 days in group standard housing
facilities, in temperature controlled rooms (15–25 °C). Before
the experiments the sheep were fasted overnight, but given
free access to water. An ultrasound study was performed to
confirm the pregnancy and the gestational age. The gestation
length in sheep varies from 142 to 152 days (average 147 days).
The pregnant ewes were given general anesthesia prior to
undergoing the interventions: induction of a left-sided CDH
on gestational day 70, ETO at day 85, during the end of the
canalicular period of lung development, or LTO at day 105,
during the terminal saccular period. Cesarean section was
performed at 140 days of gestation. Vital functions of the
pregnant ewes were monitored continuously to prevent
complications.
Based on the surgical procedure, the fetuses were divided
into three groups: CDH (fetuses with induced CDH), ETO
(fetuses with induced CDH and ETO), and LTO (fetuses with
induced CDH and LTO). Consequently, five animals were
assigned to each group. Because of the high fetal mortality at
CDH induction and/or at TO, data at term were available only
for 6 fetuses (two subjects per group). Six healthy twins of
operated animals were not enrolled in this evaluation. The
control group included two littermates in case of a twin
pregnancy, not undergoing fetal surgery.
Anesthesia protocol
All surgical procedures were performed under general
anesthesia. After premedication with an intramuscular (IM)
injection of 5mg/Kg ketamine and 0.2mg/Kg midazolam
(Dormicum®, Roche), intravenous (IV) access was established
at the external jugular vein.
The pregnant ewes were pre-oxygenated using a facemask
and induced with 5mg/Kg IV propophol (Propofol®-Lipuro
1%, B. Braun Melsungen AG). Endotracheal intubation was
performed, and general anesthesia was maintained with
isoflurane 2% (Isoflo, Abbott laboratories Ltd) in 100% oxygen
(1.5 L/min).
Esophageal intubationwas performed to prevent ruminal bloat.
A continuous infusion of Ringer lactate (B. Braun Melsungen AG)
was administered at 10mL/Kg/h during surgery. Intra-operative
monitoring consisted of standard electrocardiography, pulse
oximetry, non-invasive blood pressure, and capnography.
Maternal body temperature was monitored by using a digital
probe andmaintained at 36–37 °Cwith awarming bed. All animals
received a 75μg transdermal fentanyl patch (Durogesic®, Janssen
Pharmaceutics) immediately after surgery andMeloxicam 0.5mg/
kg IM/24h for seven days for post-operative pain relief. For peri-
operative infection prophylaxis, the animals received a single dose
of 22mg/Kg IV cephazolin (Kurgan®, Normon Laboratories) at
the time of induction and 15mg/Kg IM amoxicillin (Duphamox
L.A., Fort Dodge) every 48h, for eight days. Fetuses were
anesthetized through the placenta, and additional anesthesia with
fentanyl (10μg/kg IM) and muscle relaxants pancuronium
(0,3mg/Kg IM) was administered.
Surgical technique
As a first step, a diaphragmatic hernia was surgically induced
(day 70 of gestation). A midline laparotomy exposed the gravid
uterus. The fetus was partially exteriorized from the uterus
through a 4 cm hysterotomy. A left fetal thoracotomy was
made, and part of the diaphragm was resected, and the fetal
stomach was pulled into the thorax, which was closed in one
layer. The fetus was returned to the uterus, 2 g of amoxicillin
were added to the amniotic fluid, and the uterus wall and
abdominal wall were closed.
For tracheal occlusion, again, the uterus was exteriorized
through a midline laparotomy; the fetal mouth was located
and partially exteriorized through a 2 cm hysterotomy. A
detachable latex balloon (diameter 12mm, length 28mm, filled
with maximum 2,5mL, Goldbal 5®) was endoscopically placed
into the trachea and inflated. The fetus was returned to the
uterus; again, 2 g of amoxicillin were added to the amniotic
fluid; and the uterus wall and abdominal wall were closed.
At day 140 of gestation (term= 145–150 days), lambs were
delivered via cesarean section. Lambs were euthanized with a
bolus of pentobarbital 200mg/Kg IV. The harvested hearts
were fixed in 10% buffered formalin (pH7) for 24–48 h before
histological evaluation and immunofluorescence studies. Body
weight of fetuses and lung weight were collected.
Histological evaluation and immunofluorescence staining
After fixation, the free wall of each LV was embedded in paraffin.
The blocks were serially cut into 3μm axial sections starting, just
below the atrio-ventricular valves. After hematoxylin/eosin
staining, histological analysis was performed. Endothelin-1
(ET-1) receptor A, TGF-β, and collagen I + smooth muscle
actin antibodies (ABCAM, Cambridge, UK) were used for the
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immunofluorescence evaluation. Analyses were performed
under a light microscope (Olympus® Bx61). The sections
were digitally photographed, and fluorescence signals were
analyzed using Image J software. The nucleus/cytoplasmatic
ratio23 was obtained using a semi quantitative analytical
micrometer scale.
A qualitative definition24–26 of the arteries was used, which was
based on the histological evaluation of small intramyocardial
arteries identified as vessels having a poor muscular layer,
moderate lumen, and without an evident elastic layer. The
myocardial arterial muscular wall thickness was obtained using
the image J software, and the values were calculated after
normalization for internal diameter for statistical analysis.
Statistical analysis
Histological variables were reported as the mean and standard
deviation; 200 measurements were made per sample/group, by
the same pathologist (RB) blinded to the treatment groups.
Normal distribution was checked with the Shapiro–Wilk test.
All descriptive statistical analyses were performed using the
SPSS statistical package (SPSS, Chicago).
RESULTS
Histology
The myocardial histological pattern was preserved in the
CDH and LTO groups, as compared with controls. In these
groups, myocytes had central nuclei, and cellular bodies
were connected at the extremities by fibers, each divided
by a thin connective layer. In the endomysium, a rich
number of capillaries, deriving from the coronaries, were
present (Figure 1A, B, and D).
In ETO, the LV showed increased myocyte size and a
decreased nucleus/cytoplasmatic ratio. The cytoplasm was
larger, and a poor, almost immature, and unstructured
contractile component of the cells was observed (Figure 1C).
The myocardial arteries’ appearance in the CDH, LTO, and
ETO groups showed no evident changes in terms of numbers
compared with the control group; however, differences were
noted in arterial muscular wall thickness (Figure 2). In CDH
fetuses, the arterial walls were thicker than the control group
(0.89 ± 0.07 μm vs 0.84 ± 0.09 μm). ETO was associated with a
decrease in thickness (0.72 ± 0.12 μm) compared with controls.
The LTO group showed no differences (0.82 ± 0.10 μm) with
controls.
Immunofluorescence results
TGF-β1 expression was not observed in the control or CDH
group (Supplementary Figure 1). While a weak signal was
noted in the LTO group, the ETO group showed marked
TGF-β1 expression (Figure 3C and D). ET-1 expression was
detected in all specimens; fluorescence signals were
observed in correspondence with the subendocardium, at
the highly specialized cardiac cells, such as Purkinje fibers
(Supplementary Figure 2). Only, in the ETO and LTO groups,
ET-1 was highlighted in myocardial tissue. While a slight
signal was detected in the LTO group, a stronger signal
was observed in the ETO group. In these specimens the
Figure 1 Left ventricles, hemathoxylin-eosin staining in the control group (A), CDH (B), ETO (C), LTO (D), 40×. In A, B, D, myocytes show the
typical cardiac pattern: central nuclei, and cellular bodies are connected at the extremities by fibers, each divided by a thin connective layer, at
the endomisium. A dense trophic network of blood capillaries deriving from the coronaries is present in the endomisium. Capillaries are
directly connected with muscular elements, thus providing nutritive elements. In C, the heart maintains its structural integrity and a dense net of
capillaries is still present. However, cells show increased size with a decreased nucleus/cytoplasmatic ratio, swollen cytoplasm, and immature
and poorly structured cellular contractile component (Figure 1C)
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gradient extended from the endocardium to myocardium
(confirmed at a 40× magnification: Supporting Information
Figure 2). Analysis with smooth muscle actin antibodies
confirmed the differences in wall thickness previously
reported in the groups.
Macroscopic data
The average of lung wieght/body weight ratios was smaller in
CDH than in controls (0.010 and 0.035, respectively) and higher
in ETO than in LTO (0.086 and 0.075, respectively).
DISCUSSION
Isolated CDH is still associated with high rates of mortality and
morbidity. Although predicting neonatal outcome remains a
challenge, FETO may improve neonatal survival as occlusion of
the fetal trachea prevents egress of lung fluid, hence accelerates
lung growth and pulmonary vascularization. When TO is
induced between 26 and 32weeks, it promotes fetal pulmonary
growth over four weeks.12–15,18,19 Fetuses with more severe
pulmonary hypoplasia show a diminished pulmonary response
and worse postnatal prognosis.21 Therefore, performing FETO
earlier has been suggested in cases with extremely severe CDH.
Preliminary results on the benefits of early FETO have been
recently described.21 TO performed between 22 and 24weeks’
gestation induces a significant growth in fetal pulmonary size
and remarkably improves pulmonary vascularization. The
benefits seem to persist over a longer period of almost 6weeks
following the procedure.21 Despite these improvements, the
mortality rate in neonates with CDH continues to remain high
because of persistent pulmonary hypertension,18,19 and left-
sided cardiac underdevelopment represents a poor prognostic
factor in some studies.3–6
Cardiac evaluation is an important part of the investigation in
a fetus with CDH. Prenatal sonographic detection of under-
developed left-sided heart is considered by some as a poor
prognostic factor.4–6 In CDH fetuses, the heart is displaced by
the physical presence of the abdominal contents in the chest
and flow dynamics within the heart are altered. Secondary
diminution of ventricular growth, particularly of the left heart,
has been documented in human CDH fetuses.8 The present
histologic data are in line with experimental data in the
nitrofen-induced CDH rat model.11,27
The combination of a smaller ventricular size and normal
function suggests a redistribution of cardiac output toward the
right ventricle when sustained by an adequate lung volume.
Smaller lungs are associated with impaired pulmonary blood
flow, resulting in augmented shunting through the ductus
arteriosus and higher impedance to the LV outflow. Moreover,
large lungs, and hence a higher pulmonary blood flow, lead to
improved preload of the LV.
Following FETO, a theoretical concern is that the acute
increase in intrathoracic pressure, because of the expanded
balloon and/or the rapid increase in lung volume, might
influence cardiac function.22 As shown by Rocha,2 the
increased fetal lung size after FETO is associated with
enhanced fetal pulmonary blood flow, resulting in an
increased in utero LV preload, which may ultimately lead to
larger left cardiac structures. This adaptation probably reduces
shunting through the ductus arteriosus.
As cardiac growth continues throughout in utero life,28 the
pulmonary venous return becomes an important determinant
Figure 2 Left ventricles–arterial walls. Hematoxylin–eosin staining in the control group (A), CDH (B), ETO (C), LTO (D), 40–. Small caliber
arteries show a variation in thickness. Compared with the control, group B arteries have increased muscular thickness with reduction of the
inner area. Panel C shows a marked reduction of the muscular component and a significant increase of inner vascular area with respect to
controls. In Panel D, wall arterial thickness is not different from panel A
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of LV growth in the late third trimester.29 The increased fetal lung
size and enhanced pulmonary blood flow after TO may induce
different responses and LV growth in ETO and LTO. According
to the literature, fetal cardiac response to ‘stressors’ after TO
seems to be gestational age-related, likely related to milestones
in fetal cardiac development, as the myocardium prepares for
ex utero life.30
In our study, the cardiac histological pattern was preserved in
CDHand LTO fetuses. Surprisingly, in ETO, increases inmyocyte
cell size and a stronger expression of ET-1 were noted. Data from
our study may be interpreted as indicative of functional
adaptation of the cardiovascular system. ETO could contribute
to high pulmonary pressure, causing right-to-left shunting of
blood across the ductus arteriosus and foramen ovale with a
possible subsequent myocardial, intra-myocardial, and
interstitial stasis. Myocardial enlargement at this age of gestation
(85 days) may be a compensatory response of myocardial tissue
upon increased mechanical load. That condition may influence
growth, maturation, and function of the myocytes.29–33 ETO
may thus induce structural changes in the left ventricular
chambers to compensate for a LV that is unable to satisfy the
increased demands or only at the expense of normal function
at this age of gestation.
The strong ET-1 expression supports the hypothesis that ETO
increases the amount of contractile myofibers.
ET-1 is a vasoactive peptide which is produced by a variety of
cells, including cardiac myocytes. In addition to its
vasoconstrictive effects, it has a potent mitogenic effect. ET-1
has been well documented in different studies in vivo and
in vitro as one of the crucial factors in the development of
cardiomyocyte hypertrophy.32,34
This study also showed higher TGF-β1 expression in ETO
than in LTO specimens. TGF-β1 is a locally generated cytokine,
and it may play a central role in protecting the heart during the
hypertrophic response by helping to restore normal function of
the affected myocardium.34 Altered expression and biological
activity of TGF-β1 in hypertrophic cardiomyocytes have been
described, and it is likely that ET-1 regulates TGF-β1 expression
in cardiac cells.32,35–37 However, the relation and interaction
between TGF-β1 and ET-1 remains unclear.32 The different
TGF-β1 and ET-1 expression in LTO supports the idea that
LTO has a protective role on the cardiomyocyte.
A difference in cardiac arterial wall thickness between groups
was observed in this preliminary study. In CDH, the muscular
compartment was thicker than in the control group. In the LTO
group, wall thickness was not different with respect to controls,
while a reduction in arterial wall thickness in the ETO group
was documented. Our data suggest that the adverse effects of
CDH in fetuses are probably not restricted to the lung yet also
involve LV myocardial cells and vessels.
We recognize that there were several limitations to this
study. First, our data are mainly qualitative. In addition,
observations in only two fetuses per group limits a proper
statistical analysis. A quantitative analysis would help
provide a better understanding of the cardiac impairment.
We did not provide any confirmation at the protein or
RNA level, nor were there cardiac functional or structural
evaluations conducted in vivo. Also, clinical studies would
need to confirm these observations. Finally, our assessment
focused only on cardiac structures.
CONCLUSIONS
This study provides early data concerning left cardiac ventricular
responses to TOprocedures. Our preliminary results suggest that
CDH and sustained TO have effects on myocardial cells and
cardiac vascularization. The time point at which TO is performed
seems to have an effect on cardiac morphology. Functional and
clinical studies are mandatory to confirm the results.
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WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• Fetal tracheal occlusion (TO) may ameliorate the prognosis in CDH.
• Fetal TO improves lung size and pulmonary vascularization.
• Cardiac structural changes and effects after fetal TO are poorly
described.
• Late TO promotes fetal pulmonary growth over four weeks.
• Early TO improves the pulmonary response in extremely severe CDH
over six weeks.
WHAT DOES THIS STUDY ADD?
• Early TO stimulates myocardial cell enlargement.
• Early TO induces cellular edema and inhibits growth.
• Early TO seems to reduce the vascular arterial wall thickness.
• Late TO seems to protect cardiomyocytes from cell edema.
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